Ad is loading...
JPGSX
Price
$89.16
Change
-$1.83 (-2.01%)
Updated
Nov 15 closing price
RGAFX
Price
$80.01
Change
-$1.34 (-1.65%)
Updated
Nov 15 closing price
Ad is loading...

JPGSX vs RGAFX

Header iconJPGSX vs RGAFX Comparison
Open Charts JPGSX vs RGAFXBanner chart's image
JPMorgan U.S. GARP Equity I
Price$89.16
Change-$1.83 (-2.01%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R5
Price$80.01
Change-$1.34 (-1.65%)
VolumeN/A
CapitalizationN/A
JPGSX vs RGAFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JPGSX vs. RGAFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JPGSX is a StrongBuy and RGAFX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RGAFX has more cash in the bank: 298B vs. JPGSX (1.63B). RGAFX pays higher dividends than JPGSX: RGAFX (0.73) vs JPGSX (0.27). JPGSX was incepted earlier than RGAFX: JPGSX (22 years) vs RGAFX (23 years). JPGSX is a more actively managed with annual turnover of: 45.00 vs. RGAFX (31.00). RGAFX has a lower initial minimum investment than JPGSX: RGAFX (250) vs JPGSX (1000000). JPGSX annual gain was more profitable for investors over the last year : 37.03 vs. RGAFX (28.35). RGAFX return over 5 years is better than : 54.30 vs. JPGSX (49.80).
JPGSXRGAFXJPGSX / RGAFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years23 years-
Gain YTD30.44626.779114%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.63B298B1%
Annual Yield % from dividends0.270.7338%
Returns for 1 year37.0328.35131%
Returns for 3 years6.98-3.86-181%
Returns for 5 years49.8054.3092%
Returns for 10 years129.8172.35179%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HRB60.080.94
+1.59%
H&R Block
ENZ1.04N/A
N/A
Enzo Biochem
TNGX3.85-0.07
-1.79%
Tango Therapeutics
UDMY7.96-0.19
-2.33%
Udemy
BMY56.22-2.28
-3.90%
Bristol-Myers Squibb Co